A multiple-dose pharmacokinetic dose selection study of hydroxyprogesterone (LPCN 1107) in pregnant women
Phase of Trial: Phase I
Latest Information Update: 16 Feb 2016
At a glance
- Drugs Hydroxyprogesterone (Primary)
- Indications Preterm birth
- Focus Pharmacokinetics
- 16 Feb 2016 Top-line results published in a Lipocine media release.
- 12 Nov 2015 According to a Lipocine media release, first patient from this trial has been dosed.
- 28 Sep 2015 Status changed from planning to recruiting according to a Lipocine media release.